{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-026270","form_type":"8-K","ticker":"TSNDF","cik":"0001778129","company_name":"TerrAscend Corp.","filed_at":"2022-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.082832+00:00","generated_at":"2026-06-21T06:52:35.282091+00:00","sec_items":["1.01","3.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"TerrAscend settles $20M USD and CAD 93.7M debt with Canopy USA; issues exchangeable shares and warrants","bullets":["Extinguished $20M USD non-convertible debenture from Arise Bioscience and CAD 80.5M + CAD 13.2M obligations from TerrAscend Canada.","Cancelled existing TerrAscend warrants to purchase 22,474,130 common shares at CAD $3.74-$17.19.","Issued 24,601,467 new exchangeable shares (exchangeable 1:1 for common upon federal legalization or exchange policy change).","Issued new warrants to purchase 22,474,130 common shares at CAD $3.74-$17.19, expiring December 31, 2032."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-026270","json":"https://secwatch.observer/filing/0000950170-22-026270.json","markdown":"https://secwatch.observer/filing/0000950170-22-026270.md","text":"https://secwatch.observer/filing/0000950170-22-026270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1778129/000095017022026270/0000950170-22-026270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1778129/000095017022026270/trssf-20221209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T06:52:35.282091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"87eb7d0fc6426b76f48e3e0e99410fceb8c6df3d","claim":"TerrAscend Corp. entered into Debt Settlement Agreement with Canopy USA, LLC, Canopy USA I Limited Partnership and Canopy USA III Limited Partnership (effective 2022-12-09).","evidence_excerpt":"On December 9, 2022, TerrAscend Corp., an Ontario corporation (“TerrAscend”), Arise Bioscience, Inc. (“Arise”), a Delaware corporation and a wholly-owned subsidiary of TerrAscend and TerrAscend Canada Inc. (“TerrAscend Canada”), an Ontario corporation and wholly-owned subsidiary of TerrAscend (collectively, the “Debt Issuers”), entered into a Debt Settlement Agreement (the “Debt Settlement Agreement”) with Canopy USA, LLC (“Canopy USA”), Canopy USA I Limited Partnership and Canopy USA III Limited Partnership (collectively, the “Canopy USA Entities”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1778129/000095017022026270/0000950170-22-026270-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Canopy USA, LLC, Canopy USA I Limited Partnership and Canopy USA III Limited Partnership"},{"label":"Effective","value":"2022-12-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}